
1. j trop med hyg. 2011 jul;85(1):22-5. doi: 10.4269/ajtmh.2011.10-0523.

molecular epidemiology malaria cameroon. xxx. sequence analysis of
plasmodium falciparum atpase 6, dihydrofolate reductase, dihydropteroate
synthase resistance markers clinical isolates children treated an
artesunate-sulfadoxine-pyrimethamine combination.

menemedengue v(1), sahnouni k, basco l, tahar r.

author information: 
(1)organisation de coordination pour la lutte contre les endémies en afrique
centrale, institut de recherche pour le développement, yaoundé, cameroon.

plasmodium falciparum dihydrofolate reductase (dhfr) dihydropteroate synthase
(dhps) genes reliable molecular markers antifolate resistance. p.
falciparum atpase 6 (pfatp6) gene proposed potential marker 
artemisinin resistance. previous clinical study, showed that
artesunate-sulfadoxine-pyrimethamine highly effective uncomplicated
malaria yaoundé, cameroon. present study, dhfr, dhps, pfatp6
mutations p. falciparum isolates obtained children treated with
artesunate-sulfadoxine-pyrimethamine determined. 61 isolates had
wild-type pfatp6 263, 623, 769 alleles, 11 (18%) single e431k
substitution. three additional mutations, e643q, e432k, e641q, detected.
the results indicate warning signal serious concern (i.e., no
parasites seen quintuple dhfr-dhps, dhfr ile164leu, pfatp6
mutations), confirmed high clinical efficacy of
artesunate-sulfadoxine-pyrimethamine. studies required identify 
molecular marker reliably predicts artemisinin resistance.

doi: 10.4269/ajtmh.2011.10-0523 
pmcid: pmc3122338
pmid: 21734119  [indexed medline]

